ambroxol has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ambroxol hydrochloride (AH), a respiratory tract lubricant and expectorant, is often used to treat chronic respiratory diseases, such as bronchial asthma, emphysema, tuberculosis, and cough." | 8.31 | Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics. ( Deng, X; Guo, P; He, J; Jia, B; Li, J; Liu, Z; Peng, H; Pi, J; Qi, D; Zhang, Y, 2023) |
| " Ambroxol hydrochloride (AH), a respiratory tract lubricant and expectorant, is often used to treat chronic respiratory diseases, such as bronchial asthma, emphysema, tuberculosis, and cough." | 4.31 | Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics. ( Deng, X; Guo, P; He, J; Jia, B; Li, J; Liu, Z; Peng, H; Pi, J; Qi, D; Zhang, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, D | 1 |
| Jia, B | 1 |
| Peng, H | 1 |
| He, J | 1 |
| Pi, J | 1 |
| Guo, P | 1 |
| Zhang, Y | 1 |
| Deng, X | 1 |
| Li, J | 1 |
| Liu, Z | 1 |
1 other study available for ambroxol and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics.
Topics: Administration, Inhalation; Ambroxol; Cough; Dry Powder Inhalers; Humans; Idiopathic Pulmonary Fibro | 2023 |